Abstract:Background: Tumor markers are routinely measured in clinical oncology. However, their value in cancer detection has been controversial largely because no single tumor marker is sensitive and specific enough to meet strict diagnostic criteria. One strategy to overcome the shortcomings of single tumor markers is to measure a combination of tumor markers to increase sensitivity and look for distinct patterns to increase specificity. This study aimed to develop a system for parallel detection of tumor markers as a tool for tumor detection in both cancer patients and asymptomatic populations at high risk. Materials and Methods: A protein chip was fabricated with twelve monoclonal antibodies against the following tumor markers respective : CA 125, CA 153, CA19-9, CA242, CEA, AFP, PSA, free-PSA, HGH, beta-HCG, NSE and ferritin. Tumor markers were captured after the protein chip was incubated with serum samples. A secondary antibody conjugated with HRP was used to detect the captured tumor markers using chemiluminescence technique. Quantification of the tumor markers was obtained after calibration with standard curves. Results: The chip system showed an overall sensitivity of 68.18% after testing 1147 cancer patients, with high sensitivities for liver, pancreas and ovarian tumors and low sensitivities for gastrointestinal tumors, and a specificity of 97.1% after testing 793 healthy individuals. Application of the chip system in physical checkups of. 15,867 individuals resulted in 16 cases that were subsequently confirmed as having cancers. Analysis of the detection results with a Support Vector. Machine algorithm considerably increased the specificity of the system as reflected in healthy individuals and hepatitis/cirrhosis patients, but only modestly decreased the sensitivity for cancer patients. Conclusion: This protein chip system is a potential tool for assisting cancer diagnosis and for screening cancer in high-risk populations.

Application of Biochips in Cancer Diagnosis

Recent Advances in Microfluidic Technology and Applications for Anti-Cancer Drug Screening

Multifunctional microfluidic chip for cancer diagnosis and treatment

The Application of Bio-Nanotechnology in Tumor Diagnosis and Treatment: A View

MICROFLUIDIC CHIP FOR CANCER CELL DETECTION AND DIAGNOSIS

Application of bio-chip in lung cancer research]

A protein chip system for parallel analysis of multi-tumor markers and its application in cancer detection.

The application of biochip technology in traditional Chinese medicine

Microfluidic Barcode Biochips for High-Throughput Real-Time Biomolecule and Single-Cell Screening

Applications of Biochip on the Screening and Identification of the Biomarkers of NPC

Application of Biochip Technology in Drug Discovery and Development

Construction of cancer-on-a-chip for drug screening

ZnO nanowire-integrated bio-microchips for specific capture and non-destructive release of circulating tumor cells

The medical and pharmaceutical applications of low density protein biochips

Gene Chip Technology and Its Application in Investigation of Anticancer Medicament

Tumor-on-a-chip: from bioinspired design to biomedical application

Application of microfluidic chips in anticancer drug screening

Application of Gene Chips in Medical Research

Biochip Technology A11d Basic Medical Science Research

Application of biochip in microbial detection

Applications of genechip technology in antineoplastic and cancer treatment